Yüklüyor......
Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
Brazil currently has a 10-valent pneumococcal conjugate vaccine (PCV10) pediatric national immunization program (NIP). However, in recent years, there has been significant progressive increases in pneumococcal disease attributed to serotypes 3, 6A, and 19A, which are covered by the 13-valent PCV (PC...
Kaydedildi:
| Yayımlandı: | Hum Vaccin Immunother |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018448/ https://ncbi.nlm.nih.gov/pubmed/32966176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1809266 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|